Idorsia Aktie

0,73CHF 0,03CHF 4,81%
Idorsia für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN DE: A2DTEB / ISIN: CH0363463438
<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2019 2020 2021 2022 2023
Personal am Ende des Jahres 0 0 0 0 0
Umsatz pro Mitarbeiter in Mio. EUR 0,00 0,00 0,00 0,00 0,00

Bilanz (in Mio. CHF) - Aktiva

2019 2020 2021 2022 2023
Summe Umlaufvermögen 775 1 035 1 077 596 276
Summe Anlagevermögen 229 401 405 308 224
Summe Aktiva 1 004 1 435 1 483 904 500

Bilanz (in Mio. CHF) - Passiva

2019 2020 2021 2022 2023
Summe Fremdkapital 840 850 1 379 1 565 1 469
Summe Eigenkapital 164 585 104 -661 -969
Summe Passiva 1 004 1 435 1 483 904 500

Adresse

Hegenheimermattweg 91, 4123 Allschwil
Telefon +41 (58) 844-00-00
Internet http://www.idorsia.com

Management

Alberto Gimona
Head-Global Clinical Development & Executive VP
Alexander Khatuntsev
Senior VP & Head-Global Human Resources
Andrew C. Weiss
SVP, Head-Corporate Communication & IR
André C. Muller
Chief Executive Officer
Antonio Olivieri
Chief Medical Officer
Arno Groenewoud
Chief Financial Officer
Felix R. Ehrat
Non-Executive Director
Jean-Paul Clozel
Chairman
Julien Gander
Senior Vice President & Group General Counsel
Jörn Aldag
Non-Executive Director
Martine Clozel
Chief Scientific Officer & Executive VP
Mathieu Simon
Vice Chairman
Peter N. Kellogg
Non-Executive Director
Sandesh Mahatme
Non-Executive Director
Simon Jose
Chief Commercial Officer & Executive VP
Sophie Kornowski-Bonnet
Non-Executive Director
Srishti Gupta
Non-Executive Director